Cite
HARVARD Citation
Ho, C. et al. (2021). HER2 mediates clinical resistance to the KRASG12C inhibitor sotorasib, which is overcome by co-targeting SHP2. European journal of cancer. pp. 16-23. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ho, C. et al. (2021). HER2 mediates clinical resistance to the KRASG12C inhibitor sotorasib, which is overcome by co-targeting SHP2. European journal of cancer. pp. 16-23. [Online].